Journal Article

Triple-Negative Breast Cancer and Predictive Markers of Response to Neoadjuvant Chemotherapy: A Systematic Review

Jager, Agnes, Debets, Reno, Kok, Marleen, Nguyen, Anh H., van den Ende, Nadine S., van Deurzen, Carolien H. M.

2023

Overview

Around 40–50% of all triple-negative breast cancer (TNBC) patients achieve a pathological complete response (pCR) after treatment with neoadjuvant chemotherapy (NAC). The identification of biomarkers predicting the response to NAC could be helpful for personalized treatment. This systematic review provides an overview of putative biomarkers at baseline that are predictive for a pCR following NAC. Embase, Medline and Web of Science were searched for articles published between January 2010 and August 2022. The articles had to meet the following criteria: patients with primary invasive TNBC without distant metastases and patients must have received NAC. In total, 2045 articles were screened by two reviewers resulting in the inclusion of 92 articles. Overall, the most frequently reported biomarkers associated with a pCR were a high expression of Ki-67, an expression of PD-L1 and the abundance of tumor-infiltrating lymphocytes, particularly CD8+ T cells, and corresponding immune gene signatures. In addition, our review reveals proteomic, genomic and transcriptomic markers that relate to cancer cells, the tumor microenvironment and the peripheral blood, which also affect chemo-sensitivity. We conclude that a prediction model based on a combination of tumor and immune markers is likely to better stratify TNBC patients with respect to NAC response.

• Publisher: MDPI AG,MDPI
• Subject: Androgens / Apoptosis / Biomarkers / Biomarkers - metabolism / Breast cancer / Cancer therapies / Chemotherapy / Gene amplification / Humans / Lymphocytes, Tumor-Infiltrating / Medical prognosis / Metastasis / Mutation / Neoadjuvant Therapy / Protein expression / Proteins / Proteomics / Review / Triple Negative Breast Neoplasms - drug therapy / Triple Negative Breast Neoplasms - genetics / Triple Negative Breast Neoplasms - metabolism / Tumor Microenvironment / Tumors